Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology Dominates Japan Approvals, Though Overall Tally Is Lower

Aug 09 2016

• By Ian Haydock

ApproveOnKeyboard_1200x675

Related Content

Japan’s Crossroads: PhRMA’s Scangos Warns Of Policy Change Fallout

Jun 13 2016

Japan PMDA To Kick Off New Asia Training Center

Mar 17 2016

Japan First To Approve Omarigliptin, Lusutrombopag

Sep 30 2015

Speedy review for pioneering drugs: understanding Japan's new Sakigake process

Apr 21 2015

Related Companies

Merck & Co., Inc.

Shionogi & Co. Ltd.

Bristol Myers Squibb Company

AstraZeneca PLC

Alexion Pharmaceuticals Inc.

Novartis AG

Bayer AG

Kyowa Kirin Co., Ltd.

Boehringer Ingelheim GmbH

Otsuka Holdings Co., Ltd.

Sanofi

Eli Lilly and Company

Asahi Kasei Corporation

Takeda Pharmaceutical Co. Ltd.

Pfizer Inc.

Torii Pharmaceutical Co. Ltd.

Kissei Pharmaceutical Co., Ltd

AbbVie Inc.

Otsuka Holdings Co., Ltd.

Maruho Co., Ltd.

Sanwa Kagaku Kenkyusho Co., Ltd.

Santen Pharmaceutical Co., Ltd.

Amgen, Inc.

Minophagen Pharmaceutical Co., Ltd.

Baxter International Inc.

Eisai Co., Ltd.

Johnson & Johnson

GSK plc

Meiji Seika Pharma Co., Ltd

Additional Topics

Japan Asia Pacific Approvals Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window